Sarepta Therapeutics, INC.
Based in CA
AI Overview
With $6.3M in lobbying spend across 35 quarterly filings, Sarepta Therapeutics, INC is one of the biggest lobbying spenders in Washington. Their lobbying covers 6 issue areas. Active from 2018 to 2025.
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2018 | $540K |
| 2019 | $930K |
| 2020 | $490K |
| 2021 | $560K |
| 2022 | $630K |
| 2023 | $910K |
| 2024 | $1.0M |
| 2025 | $1.2M |
Issues Lobbied
Lobbying Firms
Lobbyists
Government Agencies Targeted
These are the government entities that Sarepta Therapeutics, INC. disclosed contacting in their lobbying filings.
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Budget/Appropriations, Health Issues, Medicare/Medicaid, Taxation, Science/Technology and 1 more
S.Con.Res. 25 - Senate Budget Resolution
H.Res. 553 - House Budget Resolution
HR 244 - Consolidated Appropriations Act of 2017
H.J.Res. 123, HR 1370 - Continuing Resolution
appropriations generally,
Issues: Innovation, Duchenne muscular dystrophy, platform technologies
PL 114-255 - 21st Century Cures implementation
S.204 - Right to Try Act of 2017
S.771 - Improving Access To Affordable Prescripti
Medicaid Drug Rebate Program, coverage, state level implementation, waivers
H.R. 3921 - Healthy Kids Act
S. 1827 - Kids Act of 2017
Request support for enforcement of existing law
Communication regarding education and outreach of company; Communication regarding Newborn Screening Saves Lives Reauthorization Act; Communication regarding guidance on Indications and Usage Section
Related Analysis
Related Investigations
Similar Clients
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.